Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function [clinicaltrials:NCT00232531]
Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function [clinicaltrials:NCT00232531]
Bio2RDF identifier
NCT00232531
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00232531
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
AIM 1 will test the hyp ...... isk of cardiovascular events.
brief title [clinicaltrials_vocabulary:brief-title]
Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2009-02-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Patients will be random ...... will undergo MR examination.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-10-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-01-26T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00232531
official title [clinicaltrials_vocabulary:official-title]
Cardiovascular Magnetic Resona ...... ration of Endothelial Function
org study id [clinicaltrials_vocabulary:org-study-id]
04.OXA.020
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-09-01T00:00:00Z
identifier
clinicaltrials:NCT00232531
title
Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
@en
type
label
Oxford Niaspan Study: Effects ...... n [clinicaltrials:NCT00232531]
@en